AI Powered Digital Biomarkers
are Driving Change in Clinical Trials
AI Powered Digital Biomarkers are
Driving Change in Clinical Trials
Utilization of Imaging Biomarkers in Clinical Trials Has Grown 700%
Utilization of Imaging Biomarkers in Clinical Trials Has Grown 700%
VIDA Intelligence Platform TM
We enable sponsors to collect and leverage high quality imaging data throughout the drug development and clinical trial process.Our services are enabled by the VIDA Intelligence Platform.
We enable sponsors to collect and leverage high quality imaging data throughout the drug development and clinical trial process.
Our services are enabled by the VIDA Intelligence Platform.
Clinical Trial Imaging
VIDA’s platform-enabled services enable exceptional imaging data quality & highly efficient site operations.
AI-Powered Digital Biomarkers
Image analysis includes radiology assessments (e.g., eligibility reads, safety reads, adjudication) and AI-powered algorithms to produce quantitative imaging biomarkers.
Site Management
Site management includes digital site onboarding activities (e.g., site training, scanner certification) and ongoing proactive site support throughout the trial.
Sponsor Trial Orchestration
VIDA’s platform offers sponsors access to trial imaging data, key performance metrics, site activity, and more.
Research and Commercial Planning
Clinical and operational data informs biomarker & site selection, in addition to novel services like external control arms & digital twins.
Trial Workflow Design
VIDA assists with trial workflow strategies (e.g. considerations for safety reads, adjudication, etc.).
Site Matching
Sponsors can leverage operational data to select high-performing sites that meet trial criteria. VIDA’s network of freestanding imaging facilities can be paired with trial centers who lack imaging capabilities, and/or to expand geographic access to trial imaging.
External Control Arms
Reduce trial size by creating a control arm from the digital biobank.
Therapeutic Research
Researchers and sponsors leverage rich data repositories to examine cohorts, better understand disease, & discover new biomarkers.
Disease Phenotyping
Discover patterns in the data to inform more targeted therapies.
Biomarker Discovery
Identify new digital biomarkers behind responder cohorts.
Retrospective Analysis
Leverage the ongoing value of high quality imaging datasets by applying new biomarkers to the data.
Therapeutic Areas
Therapeutic Areas
Any trial with imaging can benefit from our platform-based
trial imaging services & expert reading services.
Our AI-powered imaging biomarkers span all major respiratory
diseases, and now include digital biomarkers for cardiovascular
and oncology trials. With best-in-breed partnerships, we are quickly
integrating AI-powered analysis across new modalities & therapeutics.
Any trial with imaging can benefit from our platform-based trial imaging services & expert reading services.
Our AI-powered imaging biomarkers span all major respiratory diseases, and now include digital biomarkers for cardiovascular and oncology trials. With best-in-breed partnerships, we are quickly integrating AI-powered analysis across new modalities & therapeutics.
Respiratory
VIDA’s foundation is quantitative imaging for all major respiratory diseases, including COPD, asthma, interstitial lung diseases, cystic fibrosis, COVID-19, and more.
We produce up to 15,000 individual metrics from a single imaging scan, spanning 50+ biomarkers to measure airway, tissue, and vascular remodel, along with lung function (e.g., ventilation, air trapping).
Cardiovascular
Several major cardiovascular conditions, noted below, are serviced by VIDA’s range of vascular and cardiac biomarkers. VIDA’s cardiovascular biomarkers include CT and MRI-based data, from gated/non-gated, or contrast/non-contrast acquisitions.
Oncology
VIDA’s oncology biomarker offering includes standard tumor response measures like RECIST 1.1, in addition to more advanced tumor analysis.
VIDA’s oncology capabilities spans solid tumors in the chest or body, imaged with CT, MRI or PET/CT scanners.
Neurology
VIDA’s team of expert radiology reviewers provides quantitative analysis for neurology trials.
Musculoskeletal
VIDA’s team of expert radiology reviewers provides quantitative analysis for MSK trials.
Gastroenterology
VIDA’s team of expert radiology reviewers provides quantitative analysis for gastroenterology trials.
What is a Digital Biobank?
A digital biobank is analogous to a traditional tissue/blood biobank, but for digital patient information over time, including imaging data, test results, demographics, diagnoses, and much more.
The Power of a Digital Biobank
Life-sciences companies are leveraging digital biobanks and AI to modernize drug development and clinical trials.
Data Security and Compliance
Data Security and Compliance
VIDA’s data security and privacy practices are HIPAA compliant. Our quality system is certified to the ISO 13485:2016 standard, complies with FDA Part 11 requirements, and reflects security and privacy measures that align with industry standard best practices. Data is secured with AES256-bit encryption.
Strategic Partners
Experience the future of lung function
analysis with Polarean’s innovative Xenon
MRI solution, now integrated into the VIDA
Intelligence Platform for trial sponsors.
VIDA’s cloud platform powers OSIC Cloud,
the world’s largest and most diverse global
repository for interstitial lung diseases.
VIDA leverages the latest aws technologies
for the VIDA Intelligence Platform.
Our Leadership Team
Our
Leadership Team
Susan Wood, PhD 
CEO
Dr. Wood has 25+ years of experience championing innovative clinical solutions to the marketplace, from concept to revenue. Dr. Wood received her Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and Public Health.
Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function using high-resolution CT imaging. She also holds a Master of Science degree in Biomedical Engineering from Duke University, and a Bachelor of Science in Engineering from the University of Maryland, College Park.
Sandra Stapleton
COO
Ms. Stapleton has over 20 years’ experience in building and managing operational and engineering functions, as well as developing leading-edge products in the healthcare field. She received her MSc. in Medical Biophysics from the University of Toronto.
Todd Johnson
CTO
Mr. Johnson has over 25 years of experience in the clinical imaging and healthcare IT industries. He received degrees in Biomedical & Electrical Engineering from the University of Iowa, and earned his MBA from the University of Minnesota.